ANDA 90360, held by Barr. Buprenorphine Hydrochloride.
As of Nov 16, 2026, ANDA 90360 (Buprenorphine Hydrochloride), held by Barr, was first approved by FDA on May 7, 2010, with 26 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 7, 2010 | Original application | Approved |
| Buprenorphine HydrochlorideEQ 2MG BASE · tablet;sublingual | Buprenorphine Hydrochloride | Discontinued |
| Buprenorphine HydrochlorideEQ 8MG BASE · tablet;sublingual | Buprenorphine Hydrochloride | Discontinued |
| Aug 14, 2026 | Supplement 32REMS | Approved | None posted |
| Dec 22, 2025 | Supplement 30Labeling · Standard review | Approved | None posted |
| Feb 21, 2025 | Supplement 29REMS | Approved | None posted |
| Mar 20, 2024 | Supplement 25REMS | Approved | None posted |
| Dec 15, 2023 | Supplement 28Labeling · Standard review | Approved | None posted |
| Jun 17, 2023 | Supplement 23Labeling · Standard review | Approved | None posted |
| Jun 17, 2023 | Supplement 21Labeling · Standard review | Approved | None posted |
| Jun 7, 2023 | Supplement 27Labeling · Standard review | Approved | None posted |
| Jun 7, 2023 | Supplement 26Labeling · Standard review | Approved | None posted |
| Dec 16, 2022 | Supplement 24REMS | Approved | None posted |
| Jun 14, 2022 | Supplement 19Labeling · Standard review | Approved | None posted |
| May 3, 2022 | Supplement 22REMS | Approved | None posted |
| Mar 4, 2021 | Supplement 18Labeling · Standard review | Approved | None posted |
| Oct 8, 2019 | Supplement 17Labeling · Standard review | Approved | None posted |
| Oct 31, 2018 | Supplement 16REMS | Approved | None posted |
| Feb 1, 2018 | Supplement 15Labeling · Standard review | Approved | None posted |
| May 23, 2017 | Supplement 14REMS | Approved | None posted |
| Mar 22, 2017 | Supplement 13Labeling · Standard review | Approved | None posted |
| Dec 16, 2016 | Supplement 12Labeling · Standard review | Approved | None posted |
| Dec 16, 2016 | Supplement 11Labeling · Standard review | Approved | None posted |
| Jul 7, 2016 | Supplement 10REMS | Approved | None posted |
| Feb 12, 2015 | Supplement 7REMS | Approved | None posted |
| Feb 4, 2015 | Supplement 8Labeling · Standard review | Approved | None posted |
| Feb 4, 2015 | Supplement 2Labeling | Approved | None posted |
| Sep 4, 2013 | Supplement 6REMS | Approved | None posted |
| Feb 22, 2013 | Supplement 4Labeling · Standard review | Approved | None posted |
| May 7, 2010 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters